Drug abuse and kidney

Hippokratia

Volumn 15, Issue SUPPL. 2, 2011, Pages 4-8

  Pantelias, K ^a   Grapsa, E ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Acute renal failure; Drug abuse; Glomerulonephritis; Heroin nephropathy; Review

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ANABOLIC AGENT; ANTIRETROVIRUS AGENT; CANNABIS; COCAINE; CREATINE KINASE; CREATININE; DIAMORPHINE; DIAZEPAM; MORPHINE; MYOGLOBIN; OXYCODONE; PHOSPHORUS; POTASSIUM; TEMAZEPAM; TOLUENE; UREA;

ACUTE KIDNEY FAILURE; AMYLOIDOSIS; ANAPHYLACTOID PURPURA; ANEMIA; BACTERIAL INFECTION; CHRONIC KIDNEY FAILURE; COMA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG ABUSE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG UPTAKE; DRUG USE; ELECTROLYTE DISTURBANCE; ELECTRON MICROSCOPY; FOCAL GLOMERULOSCLEROSIS; GASTROENTERITIS; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; HEART ARRHYTHMIA; HEROIN NEPHROPATHY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HYPERPLASIA; HYPERTENSION; HYPOALBUMINEMIA; INCIDENCE; INTRAVENOUS DRUG ABUSE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; LABORATORY TEST; LEUKOCYTOSIS; MALIGNANT HYPERTENSION; MICROALBUMINURIA; MULTIPLE ORGAN FAILURE; MUSCLE INJURY; MYALGIA; MYCOSIS; NECROTIZING ARTERITIS; NEPHROTIC SYNDROME; NEPHROTOXICITY; PROTEINURIA; RENAL SCLERODERMA; REVIEW; RHABDOMYOLYSIS; SYMPTOMATOLOGY; THROMBOCYTOPENIA; TOXIC HEPATITIS; VIRUS INFECTION;

EID: 83255166540     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Crowe AV, Howse M, Bell GM, Henry JA. Substances abuse and kidney. QJM. 2000; 93: 147-152.
2. Strang J. Substance Abuse: The Size of the Problem. Medicine. 1995; 23: 41-45.
3. Institute for the Study of Drug Dependence. General statistical information about drugs. November 1997. http://www.drugscope.org.uk/Resources"
4. European Monitoring Centre for Drugs and Drug Addiction. Statistics, country overviews: Greece. Http://www.emcdda.europa.eu/publications/country-overviews/el.
5. European Monitoring Centre for Drugs and Drug Addiction. Publications, 2010 annual report online. EMCDDA 2010 Annual report - online version Drug-related infectious diseases and deaths - Drug-related deaths and mortality. http://www.emcdda. europa.eu/online/annual-report/2010/diseases-and-deaths/4.
6. Coordinating body of drug prosecution, National Unit of information "report on drugs in Greece year 2007".
7. Mercadante S, Ferrera P, Villari P, Casuccio A, Intravaia G, Mangione S. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage. 2009; 37: 632-641.
8. Gerada C, Ashworth M. ABC of mental health: Addiction and dependence I: Illicit drugs. Br Med J. 1997; 315: 297-300.
9. Sreepada Rao TKS, Nicastri AD, Friedman EA. Renal consequences of narcotic abuse. Adv Nephrol. 1977; 7: 261-290.
10. Benowitz NL. Clinical pharmacology and toxicology of cocaine. Pharmacol Toxicol. 1993; 72: 3-12.
11. Dowling GP, McDonough ET, Bost RO. 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA. JAMA. 1987; 257: 1615-1617.
12. Verebey K, Alrazi J, Depace A. The complications of 'Ecstasy' (MDMA). JAMA. 1988; 259: 1649-1650.
13. Lavelle TL, Hammersley R, Forsyth A. The use of buprenorphine and temazepam by drug injectors. J Addict Dis. 1991; 10: 5-14.
14. Proudfoot AT. Acute Poisoning, 2nd edn. Butterworth-Heinneman, 1993: 145-160.
15. Richard JM, Louis J, Cantin D. Nephrotoxicity of orellanine, a toxin from the mushroom Cortinarius orellanus. Arch Toxicol. 1988; 62: 242-245.
16. Ramsey JD, Anderson HR, Bloor K, Flanagan RJ. An introduction to the practice, prevalence, and chemical toxicology of volatile substance abuse. Hum Toxicol. 1989; 8: 261-269.
17. Bruckner JV, Peterson RG. Evaluation of toluene and acetone inhalant abuse: pharmacology and pharmacodyamics. Toxicol Appl Pharmacol. 1981; 61: 27-38.
18. Meadows R, Verghese A. Medical complications of glue sniffing. South Med J. 1996; 89: 455-462.
19. Grossman RA, Hamilton RW, Morse BM, Penn AS, Goldberg M. Nontraumatic rhabdomyolysis and acute renal failure. N Engl J Med. 1974; 291: 807-811.
20. Roth D, Alarcon FJ, Fernandez JA, Preston RA, Bourgiognie JJ. Acute rhabdomyolysis associated with cocaine intoxication. N Engl J Med. 1988; 319: 673-677.
21. Gomez M, Castaneda M, Araujo AM, Martin MP, Batllori M. Consequences of heroin consumption: Compartmental syndrome and rhabdomyolysis. An Sist Sanit Navar. 2006; 29: 131-135.
22. Welch RD, Todd K, Krause GS. Incidence of cocaine-associated rhabdomyolysis. Ann Emerg Med. 1991; 20: 154-157.
23. Hsu WY, Chiu NY, Liao YC. Rhavdomyolysis and brain ischemic stroke in a heroin-dependent male under methadone maintenance therapy. Acta Psychiatr Scand. 2009; 120: 76-79.
24. Sharff JA. Renal infarction associated with intravenous cocaine use. Ann Emerg Med. 1984; 13: 1145-1147.
25. Fogo A, Superdock KR, Atkinson JB. Severe arteriosclerosis in the kidney of a cocaine addict. Am J Kid Dis. 1992; 20: 513-515.
26. Di Paolo N, Fineschi V, Di Paolo M, Wetley CV, Del Vecchio MT, Bianciardi G. Kidney vascular damage and cocaine. Clin Nephrol. 1997; 47: 298-303.
27. Furaz K, Bernis Carro C, Cirugeda Garcia A, Perez de Jose A, Tomero Sanchez JA. Renal infraction and acute renal failure due to cocaine use. Nefrologia. 2008; 28: 347-349.
28. Maxwell DL, Polkey MI, Henry JA. Hyponatraemia and catatonic stupor after taking "ecstasy". BMJ. 1993; 307: 1399.
29. Henry JA, Fallon JK, Kicman AT, Hutt AJ, Cowan DA, Forsling M. Low-dose MDMA ("ecstasy") induces vasopressin secretion. Lancet. 1998; 351: 1784.
30. Woodrow G, Harnden P, Turney JH. Acute renal failure due to accelerated hypertension following ingestion of 3,4-methylenedioxymethamphetamine ("ecstasy"). Nephrol Dial Transplant. 1995; 10: 399-400.
31. Blair SD, Holcombe C, Coombes EN, O'Malley MK. Leg ischaemia secondary to non-medical injection of temazepam. Lancet. 1991; 338: 1393-1394.
32. Jenkinson DF, Pusey CD. Rhabdomyolysis and renal failure after intra-arterial temazepam. Nephrol Dial Transplant. 1994; 9: 1334-1335.
33. Raff E, Halloran PF, Kjellstrand CM. Renal failure after eating "magic" mushrooms. Can Med Assoc J. 1992; 147: 1339-1341.
34. Short AK, Watling R, MacDonald MK, Robson JS. Poisoning by Cortinarius speciosissmus. Lancet. 1980; 2: 942-944.
35. Gupta RK, van der Meulen J, Johny KV. Oliguric acute renal failure due to glue-sniffing. Scand J Urol Nephrol. 1991; 25: 247-250.
36. Acute renal failure due to intersitital nephritis induced by 'glue sniffing' with subsequent recovery. Scot Med J. 1988; 33: 246-247.
37. Payne RJ, Brand SN. The toxicity of intravenously used marihuana. JAMA. 1975; 233: 351-354.
38. Singhal PC, Gibbons N, Abramovici M. Long term effects of morphine on mesangial cell proliferation and matrix synthesis. Kidney Int. 1992; 41: 1560-1570.
39. Roberts WC, Rabson AS. Focal glomerular lesions in fungal endocarditis. Ann Int Med. 1975; 71: 963-970.
40. Jaffe JA, Kimmel PL. Chronic nephropathies of cocaine and heroin abuse: a critical review. Clin J Am Soc Nephrol. 2006; 1: 655-667.
41. Tuazon CU, Hill R, Sheagren JN. Microbiologic study of street heroin and injection paraphernalia. J Infect Dis. 1974; 129: 327-329.
42. Manner I, Sagedal S, Røger M, Os I. Renal amyloidosis in intravenous heroin addicts with nephrotic syndrome and renal failure. Clin Nephrol. 2009; 72: 224-228.
43. Neugarten J, Gallo GR, Buxbaum J, Katz LA, Rubenstein J, Baldwin DS. Amyloidosis and subcutaneous heroin abusers ("skin poppers' amyloidosis"). Am J Med. 1986; 81: 635-640.
44. Connolly JO, Gillmore JD, Lachmann HJ, Davenport A, Hawkins PN, Woolfson RG. Renal amyloidosis in intravenous drug users. QJM. 2006; 99: 737-742.
45. Crowley S, Feinfeld DA, Janis R. Resolution of nephrotic syndrome and lack of heroin-associated renal amyloidosis. Am J Kid Dis. 1989; 13: 333-335.
46. Cunningham EE, Brentjens JR, Zielezny MA, Andres GA, Venuto RC. Heroin nephropathy. A clinicopathologic and epidemiologic study. Am J Med. 1980; 68: 47-53.
47. Friedman EA, Tao TK. Disappearance of uremia due to heroinassociated nephropathy. Am J Kid Dis. 1995; 25: 689-693.
48. D'Agati V, Suh JI, Carbone L, Cheng JT, Appel G. Pathology of HIV-associated nephropathy: A detailed morpholgic and comparative study. Kidney Int. 1989; 35: 1358-1370.
49. Pastan S, Bailey J. Dialysis therapy. N Engl J Med. 1998; 338: 1428-1437.
50. Wali RK, Drachenberg CI, Papadimitriou JC, Keay S, Ramos E. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet. 1998; 352: 783-784.
51. Santoro D, Stella M, Castellino S. Henoch-Schönlein purpura associated with acetaminophen and codeine. Clin Nephrol. 2006; 66: 131-134.
52. Hill P, Dwyer K, Kay T, Murphy B. Severe chronic renal failure in association with oxycodone addiction: a new form of fibrillary glomerulopathy. Hum Pathol. 2002; 33: 783-787.
53. Mattana J, Gibbons N, Singhal PC. Cocaine interacts with macrophages to modulate mesangial cell proliferation. J Pharmacol Exp Ther. 1994; 271: 311-318.
54. Lam M, Ballou SP. Reversible scleroderma renal crisis after cocaine use. N Engl J Med. 1992; 326: 1435.
55. Chevalier X, Rostoker G, Larget-Piet B, Gherardi R. Schoenlain- Henoch purpura with necrotizing vasculitis after cocaine snorting. Clin Nephrol. 1995; 43: 348-349.
56. Neynaber S, Mistry-Burchardi N, Rust C, Samtleben W, Burgdorf WH, Seitz MA, et al. PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse. Acta Derm Venereol. 2008; 88: 594-596.
57. Sirvent AE, Enríquez R, Andrada E, Amorós F, Gallego JA, González C, et al. Goodpasture's syndrome in a patient using cocaine--a case report and review of the literature. Clin Nephrol. 2007; 68: 182-185.
58. Bohatyrewicz M, Urasinska E, Rozanski J, Ciechanowski K. Membranous glomerulonephritis may be associated with heavy marijuana abuse. Transplant Proc. 2007; 39: 3054-3056.
59. Patel R, Benjamin J Jr. Renal disease associated with toluene inhalation. J Toxicol Clin Toxicol. 1986; 24: 213-223.
60. Streicher HZ, Gabow PA, Moss AH, Kono D, Kaehny WD. Syndromes of toluene sniffing in adults. Ann Intern Med. 1981; 94: 758-762.
61. Kaneko T, Koizumi T, Takezaki T, Sato A. Urinary calculi associated with solvent abuse. J Urol. 1992; 147: 1365-1366.
62. Venkataraman G. Renal damage and glue sniffing. Br Med J. 1981; 283: 1467.
63. Bonzel KE, Muller-Wiefel DE, Ruder H, Wingen AM, Waldherr R, Weber M. Anti-glomerular basement membrane antibodymediated glomerulonephritis due to glue sniffing. Eur J Paediatr. 1987; 146: 296-300.
64. Herlitz LC, Markowitz GS, Farris AB, Schwimmer JA, Stokes MB, Kunis C, et al. Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J. Am. Soc. Nephrol. 2010; 21: 163-172.
65. Thornhill-Joynes M, Norris KC, Witana SC, Ward HJ, Barbour B. The impact of substance abuse on hypertensive end-stage renal disease in inner city African-Americans. J Am Soc Nephrol. 1994; 5: 342.
66. Brecklin CS, Gopaniuk-Folga A, Kravetz T, Sabah S, Singh A, Arruda JAL, et al. Prevalence of hypertension in chronic cocaine users. A J Hypertension. 1998; 11: 1279-1283.
67. Dunea G, Arruda JA, Bakir AA, Share DS, Smith EC. Role of cocaine in end-stage renal disease in some hypertensive African- Americans. Am J Nephrol. 1995; 15: 5-9.